已收盤 08-29 16:00:00 美东时间
+0.070
+2.49%
Stereotaxis will showcase its surgical robotics technology at HRX 2025, a digital health conference in Atlanta, Sept 4-6. CEO David Fischel will discuss robot-enhanced electrophysiology, followed by a panel exploring advanced ablation techniques, VR, AI, and automation in heart rhythm care. The company aims to shape an innovative future for electrophysiology.
08-28 11:47
Stereotaxis (($STXS)) has held its Q2 earnings call. Read on for the main highl...
08-12 08:53
Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 30.56 percent. This is a 28.57 percent increase over losses of $(0.07) per share from the
08-08 04:03
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
公司获高额股权融资,VWAV飙涨近370%;乳腺癌药物实验效果积极,CELC大涨超167%;正式进军稳定币领域,MPU大涨超40%>>
07-29 19:19
Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance
07-28 19:49
Stereotaxis has received FDA clearance for its MAGiC Sweep™ catheter, the first robotically navigated high-density electrophysiology mapping catheter. Designed to enhance complex arrhythmia diagnosis and treatment, MAGiC Sweep offers efficient high-density mapping with 20 electrodes, extended reach, precision, an atraumatic design, and improved workflow. Experts praise its potential to revolutionize cardiac ablation procedures, and Stereotaxis pl...
07-28 11:48
Stereotaxis (NYSE: STXS), a leader in surgical robotics, will release its Q2 2025 financial results on August 7, 2025. A conference call and webcast at 4:30 p.m. ET will discuss the results and corporate updates. To join, dial 888-596-4144 (US/Canada) or 1-646-968-2525 (International), with passcode 1064613. The webcast and replay can be accessed via Stereotaxis’ investor relations website at http://ir.stereotaxis.com/. A phone replay will be ava...
07-23 12:00
Led by Strategic Industry Partner and Select Institutional InvestorsProceeds Strengthen Balance Sheet and Support Commercialization of Innovation Strategy
07-17 20:33